drugset / Trial / NCT01502735
Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This is a phase 1 study to evaluate the safety of a vaccine (DENV-1 PIV) for the prevention of dengue fever.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DENV-1 PIV | Vaccine | 2.5 ug | Intramuscular |
| Subject | DENV-1 PIV | Vaccine | 5 ug | Intramuscular |